Evolution in the prescription and cost of non-intravenous rescue benzodiazepines for the treatment of seizure emergencies.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Marta Amengual-Gual, Cristina Barcia Aguilar, Laurie Douglass, Marina Gaínza-Lein, Taha Fathima Khan, Jonas Rinat, Iván Sánchez Fernández, Alcy Torres

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: United States : Epilepsia , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 701491

OBJECTIVE: The proportion of patients with epilepsy who have a non-intravenous rescue benzodiazepine (non-IV-rBZD) available for seizure emergencies is unknown. This study aims to describe prescription patterns from 2006 to 2022, factors associated with prescription, and the impact of recently introduced intranasal benzodiazepines on prescription and cost. METHODS: Retrospective analysis of the MarketScan Database, a claims database of privately insured patients in the United States. RESULTS: Among 213 384 patients (53% female, median (p SIGNIFICANCE: The vast majority of patients with epilepsy have not filled a prescription for non-IV-rBZDs. Seizure emergency readiness can be markedly improved, especially among adults. The cost of non-IV-rBZDs has increased with intranasal rescue medications.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH